A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia

C.L. Andersen, M.F. McMullin, E. Ejerblad, S. Zweegman, C. Harrison, S. Fernandes, D. Bareford, S. Knapper, J. Samuelsson, E. Lofvenberg, O. Linder, B. Andreasson, E. Ahlstrand, M.K. Jensen, O.W. Bjerrum, H. Vestergaard, H. Larsen, T.W. Klausen, T. Mourits-Andersen, H.C. Hasselbalch

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)498-508
JournalBritish Journal of Haematology
Volume162
Issue number4
DOIs
Publication statusPublished - 2013

Cite this

Andersen, C. L., McMullin, M. F., Ejerblad, E., Zweegman, S., Harrison, C., Fernandes, S., ... Hasselbalch, H. C. (2013). A phase II study of vorinostat (MK-0683) in patients with polycythaemia vera and essential thrombocythaemia. British Journal of Haematology, 162(4), 498-508. https://doi.org/10.1111/bjh.12416